Chemistry:Manidipine
From HandWiki
Manidipine is a calcium channel blocker (dihydropyridine type) that is used clinically as an antihypertensive.[1][2][3][4][5]
It was patented in 1982 and approved for medical use in 1990.[6]
Synthesis
The alkylation between N-(2-hydroxyethyl)piperazine [103-76-4] (1) and Benzhydryl Bromide [776-74-9] (2) gives 2-(4-benzhydrylpiperazin-1-yl)ethanol [10527-64-7] (3). The reaction with Diketene [674-82-8] (4) gives 2-(4-benzhydryl-1-piperazinyl)ethyl acetoacetate [89226-49-3] (5). The reaction with 3-nitrobenzaldehyde [99-61-6] (6) and Methyl 3-aminocrotonate [14205-39-1] (7) completed the synthesis of Manidipine (8).
References
- ↑ "Manidipine: a review of its use in hypertension". Drugs 61 (12): 1777–1799. 2001. doi:10.2165/00003495-200161120-00010. PMID 11693466. http://drugs.adisonline.com/pt/re/drugs/abstract.00003495-200161120-00010.htm. Retrieved 2009-06-20.
- ↑ "Manidipine: a review of its use in the management of hypertension". Drugs 64 (17): 1923–1940. 2004. doi:10.2165/00003495-200464170-00011. PMID 15329044. http://drugs.adisonline.com/pt/re/drugs/abstract.00003495-200464170-00011.htm. Retrieved 2009-06-20.
- ↑ "Antihypertensive effect of manidipine". Drugs 65 (Suppl 2): 11–19. 2005. doi:10.2165/00003495-200565002-00003. PMID 16398058. http://drugs.adisonline.com/pt/re/drugs/abstract.00003495-200565002-00003.htm. Retrieved 2009-06-20.
- ↑ "Manidipine-delapril combination in the management of hypertension". Vascular Health and Risk Management 3 (3): 255–263. 2007. PMID 17703633.
- ↑ "Evaluation of manidipine hydrochloride, a new calcium antagonist, in the treatment of hypertensive patients with renal disorders". Current Therapeutic Research 52 (2): 248–253. August 1992. doi:10.1016/S0011-393X(05)80475-8.
- ↑ (in en) Analogue-based Drug Discovery. John Wiley & Sons. 2006. p. 465. ISBN 9783527607495. https://books.google.com/books?id=FjKfqkaKkAAC&pg=PA465.
- ↑ Meguro, Kanji; Aizawa, Masahiro; Sohda, Takashi; Kawamatsu, Yutaka; Nagaoka, Akinobu (1985). "New 1,4-dihydropyridine derivatives with potent and long-lasting hypotensive effect.". CHEMICAL & PHARMACEUTICAL BULLETIN. 33 (9): 3787–3797. ISSN 0009-2363. doi:10.1248/cpb.33.3787.
- ↑ EP0094159 idem Kanji Meguro & Akinobu Nagaoka, US4892875 (1990 to Takeda Pharmaceutical Co Ltd).
- ↑ Dharmaraj Ramachandra Rao, Rajendra Narayanrao Kankan, Maruti Ganpati Ghagare, WO20110203954 (2011 to Cipla Limited, Curtis, Philip Anthony).
- ↑ 刘玉海, et al. CN105924382 (2018).
- ↑ 金晓峰, et al. CN102875451 (2014 to CHANGZHOU PHARMACEUTICAL FACTORY CO LTD).
- ↑ 刘忠春, CN107337632 (2017).
- ↑ 谷志勇, et al. CN104292150 (2015).
- ↑ , CN103351362 (2013 to).
- ↑ http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZHOU200402000.htm
 |  |
